Proxy Results (Form 8-K)

Item 5.07 Submission of Matters to a Vote of Security Holders.

On February 5, 2025, Agape ATP Corporation. (the "Company") held its 2025 Special Meeting of Stockholders (the "Special Meeting"). All capitalized terms used herein will have the meanings set forth in the Definitive Proxy Statement Schedule 14A dated January 22, 2025 (the "Definitive Proxy Statement"). Two items of business were acted upon by the Company's stockholders at the Special Meeting, each of which was approved by the shareholders.

1. Approval, for an amendment to the Company's Articles of Incorporation, as amended to date, to increase the number of authorized shares of common stock from 50,000,000 to 500,000,000 and to conform the Articles of Incorporation to the Company's Bylaws. The voting results were as follows:

2. Approval, for purposes of Nasdaq listing rule 5635(a), of the issuance by the Company of that number of shares of Company common stock, par value $0.0001 per share that would cause the Regulation S Investors, in aggregate, to beneficially own twenty percent or more of the Common Stock or voting power of the Company, through their purchase, in aggregate, of up to 46,000,000 shares of Common Stock (the "Subscription Shares"), or approximately 92% of the issued and outstanding shares of the Company following the closing of the transaction. The Subscription Shares are to be issued pursuant to the terms of certain subscription agreements pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"), and Rule 902 of Regulation S promulgated thereunder as set forth in those certain securities subscription agreements as set forth in the Definitive Proxy Statement. The voting results were as follows: